Oncology drug development has shifted decisively towards precision immunotherapies, where biomarker-defined patient populations play a pivotal role. Immuno-oncology now represents…
Artificial intelligence has become a familiar topic in clinical trial discussions. Sponsors increasingly ask about automation, predictive insights, and smarter…
Enrollment challenges continue to be a defining constraint in nephrology research. In a January 2026 snapshot of GlobalData’s clinical trial…
Healthcare is entering a new era of digital transformation. In the US, competition among leading providers is driving rapid adoption…
Clinical trial numbers for CAR-T therapies have risen dramatically in recent years, and as these programmes expand beyond oncology into…
We spoke with Grace Breen, Senior Vice President, Quality at Sharp about the role of quality in a CDMO environment,…
Remote education is surging in demand, with nearly nine in 10 colleges planning to expand online programs. Also known as…
The cost and quality of the US healthcare system remain prominent issues for many Americans. Despite spending nearly twice as…
If you’re feeling anxious or overwhelmed attempting to balance study, work, family, and clinical practice, you are not alone. As…
AI in clinical trials has the potential to offer faster insights, greater efficiency, and improved data quality. Nowhere is this…
